NFATC2IP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.448000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.460600E-01
Normal-vs-Stage2
6.896200E-01
Normal-vs-Stage3
3.637600E-01
Normal-vs-Stage4
5.967800E-01
Stage1-vs-Stage2
3.136800E-01
Stage1-vs-Stage3
1.931610E-01
Stage1-vs-Stage4
7.387800E-01
Stage2-vs-Stage3
3.025700E-02
Stage2-vs-Stage4
6.096800E-01
Stage3-vs-Stage4
7.047800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.519800E-01
Normal-vs-AfricanAmerican
3.987600E-01
Normal-vs-Asian
5.980400E-01
Caucasian-vs-AfricanAmerican
5.138600E-01
Caucasian-vs-Asian
6.150400E-01
AfricanAmerican-vs-Asian
8.053600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.762000E-01
Normal-vs-Female
6.097200E-01
Male-vs-Female
2.453800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.155800E-01
Normal-vs-Age(41-60Yrs)
6.554400E-01
Normal-vs-Age(61-80Yrs)
6.461600E-01
Normal-vs-Age(81-100Yrs)
6.299800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.010000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.998200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.067200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.669400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.504400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.789800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.511000E-01
Normal-vs-Daily Drinker
6.491000E-01
Normal-vs-Weekly Drinker
3.713000E-01
Normal-vs-Occasional Drinker
6.124200E-01
Normal-vs-Social Drinker
8.132000E-01
Non Drinker-vs-Daily Drinker
9.847600E-01
Non Drinker-vs-Weekly Drinker
8.761600E-01
Non Drinker-vs-Occasional Drinker
7.259400E-01
Non Drinker-vs-Social Drinker
2.709200E-01
Daily Drinker-vs-Weekly Drinker
8.890400E-01
Daily Drinker-vs-Occasional Drinker
7.604000E-01
Daily Drinker-vs-Social Drinker
2.530000E-01
Weekly Drinker-vs-Occasional Drinker
9.114800E-01
Weekly Drinker-vs-Social Drinker
2.568400E-01
Occasional Drinker-vs-Social Drinker
9.372000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.392780E-01
Normal-vs-Grade 2
1.689720E-02
Normal-vs-Grade 3
1.863920E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.364300E-02
Grade 1-vs-Grade 3
7.459200E-03
Grade 1-vs-Grade 4
1.392780E-01
Grade 2-vs-Grade 3
1.597620E-01
Grade 2-vs-Grade 4
1.689720E-02
Grade 3-vs-Grade 4
1.863920E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.184600E-01
Normal-vs-NonDiabetic
6.369800E-01
Diabetic-vs-NonDiabetic
9.420200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.390400E-01
Normal-vs-NoPancreatitis
6.123200E-01
Pancreatitis-vs-NoPancreatitis
7.244400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.457400E-01
Normal-vs-N1
6.547800E-01
N0-vs-N1
8.728200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.003600E-01
Normal-vs-TP53-NonMutant
6.378400E-01
TP53-Mutant-vs-TP53-NonMutant
5.789600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
